Strategic & Technical Intelligence: A Prerequisite For Life Science Success

By Bill Kelly, president and cofounder, BioInformatics LLC

Given the dynamic nature of the life sciences industry coupled with its high financial stakes, it is prudent for a pharmaceutical company to expand its market intelligence program beyond the short-term needs of management and brand teams. Ultimately, however, a company’s long-term competitiveness depends upon the skill of its researchers in utilizing cellular and molecular biology and medicinal chemistry to discover, develop, and commercialize naturally occurring proteins, antibodies, and small molecules. As the pace of biological research increases, pharmaceutical companies must increasingly monitor strategic developments in the world’s scientific community in order to ensure their R&D scientists are fully aware of breakthroughs, emerging trends, promising approaches, and new platform technologies.